These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 17653290)
21. American College of Neuropsychopharmacology--43rd annual meeting. 12-16 December 2004, San Juan, Puerto Rico. Davis JM IDrugs; 2005 Feb; 8(2):100-3. PubMed ID: 15696406 [No Abstract] [Full Text] [Related]
22. Clinical research and the third world. Sluzki CE Am J Orthopsychiatry; 2001 Jul; 71(3):276-7. PubMed ID: 11495328 [No Abstract] [Full Text] [Related]
23. Augmentation strategies in the treatment of major depressive disorder. Clinical considerations with atypical antipsychotic augmentation. Gitlin MJ CNS Spectr; 2007 Dec; 12(12 Suppl 22):13-5. PubMed ID: 18389929 [No Abstract] [Full Text] [Related]
28. Bibliography. Current awareness in human psychopharmacology. Hum Psychopharmacol; 2006 Jun; 21(4):275-84. PubMed ID: 16869045 [No Abstract] [Full Text] [Related]
29. Clinical experience and a double-blind study of a new anti-depressant, vivactil hydrochloride. Daneman EA Psychosomatics; 1965; 6(5):342-6. PubMed ID: 5319247 [No Abstract] [Full Text] [Related]
30. Vivactil (protriptyline): a new and potent anti-depressant. Kline NS; Hackett E Psychosomatics; 1965; 6(5):330-6. PubMed ID: 5319245 [No Abstract] [Full Text] [Related]
31. Psychopharmacology for neurologists. Dubovsky SL; Dubovsky AN Semin Neurol; 2009 Jul; 29(3):200-19. PubMed ID: 19551598 [TBL] [Abstract][Full Text] [Related]
32. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms. Mercer D; Douglass AB; Links PS J Pers Disord; 2009 Apr; 23(2):156-74. PubMed ID: 19379093 [TBL] [Abstract][Full Text] [Related]
33. Effectiveness and safety of adjunctive antidepressants in the treatment of bipolar depression: a review. Harel EV; Levkovitz Y Isr J Psychiatry Relat Sci; 2008; 45(2):121-8. PubMed ID: 18982838 [TBL] [Abstract][Full Text] [Related]
34. The decline of pharmaceutical psychiatry and the increasing role of psychological medicine. Fava GA Psychother Psychosom; 2009; 78(4):220-7. PubMed ID: 19401622 [TBL] [Abstract][Full Text] [Related]
35. Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part I: monoamine oxidase inhibitors. López-Muñoz F; Alamo C; Juckel G; Assion HJ J Clin Psychopharmacol; 2007 Dec; 27(6):555-9. PubMed ID: 18004120 [No Abstract] [Full Text] [Related]
36. Mass fragmentography in clinical psychopharmacology. Bertilsson L; Sjöqvist F Adv Biochem Psychopharmacol; 1973; 7():147-59. PubMed ID: 4742805 [No Abstract] [Full Text] [Related]
37. Diagnosing and managing psychotic and mood disorders. Nasrallah HA; Black DW; Goldberg JF; Muzina DJ; Pariser SF Ann Clin Psychiatry; 2008; 20 Suppl 1():S1-28; quiz S29-30. PubMed ID: 19034748 [No Abstract] [Full Text] [Related]
38. [Augmentation with atypical antipsychotics: a realistic option in resistant depression?]. Nolen WA Tijdschr Psychiatr; 2008; 50(5):293-4. PubMed ID: 18470845 [No Abstract] [Full Text] [Related]
39. The withdrawal of antipsychotics and antidepressants from patients with dementia and BPSD living in nursing homes: an open pilot study. Bergh S; Engedal K Int J Geriatr Psychiatry; 2008 Aug; 23(8):877-9. PubMed ID: 18655022 [No Abstract] [Full Text] [Related]
40. Applications of microcomputers to clinical trials in psychopharmacology. Psychopharmacol Bull; 1987; 23(2):259-370. PubMed ID: 3615771 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]